BUILDING CAPABILITY
An analysis of the GCC’s evolving healthcare investment landscape, exploring how the…
Abu Dhabi and China Explore New Partnerships in Healthcare Innovation
Abu Dhabi’s Department of Health concludes its first healthcare mission to China,…
FDA approves Lilly’s EBGLYSS® for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
The U.S. FDA has approved a new maintenance dosing regimen for Eli…
MS Pharma Announces Strategic Growth Investment from Olayan Financing Company
MS Pharma secured a strategic minority investment from Olayan Financing Company to…
Regeneron and Telix Announce Strategic Radiopharma Collaboration
Regeneron and Telix Pharmaceuticals announce a strategic collaboration to develop next-generation radiopharmaceutical…
Living with Crohn’s Disease | What You Need to Know: Dr. Lisa Sharkey
Dr. Sharkey explains that Crohn's disease is a chronic inflammatory bowel disease…
Biosimilars & Beyond: Ravi Sharma on Access, Trust & the Future of Care
We sat down with Ravi Sharma, Chief Group Pharmacy Officer at Burjeel…
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology…
From Skin Types to Chronic Conditions: Dr. Jawaher Al Naqbi | AIDA 2025
Dr. Jaher expressed particular excitement about the conference's focus on biologics, JAK…
